ArticlebioRxiv : the preprint server for biology2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis.
Rojo A Ratsimandresy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.